> Take a look at its Animal Rabies Vaccine if you want to 'share
> positive'.

> Hardly any mention on the boards, yet it could be SVA's biggest earner
> by the end of 2010.

> Since 2008, China has implemented compulsory rabies vaccination for
> dogs. SVA has developed the only Chinese inactivated animal rabies
> vaccine - existing domestic players are only able to supply attenuated
> animal rabies vaccines. Animal rabies vaccine is the most cost-
> effective strategy for preventing rabies in humans, by eliminating
> rabies in dogs. SVA is expected to launch the vaccine in China's
> veterinary market in 2010, and has estimated its own market share of
> the animal rabies vaccine market will be about $147 million (which is
> around 20% of Chinese market).

> $147m not bad!

> On Nov 30, 5:00 pm, JimA <jame...@yahoo.com> wrote:

> > jd, the 2-in-1 is a reminder.

> > Half year ago, I got a chance to feel the CEO's ambition, so decided
> > to buy SVA with no sale for at least one year.  SVA is pursuing its
> > intentions one by one.

> > Since I have no intention to play others fear, so want to share my
> > positive and do hope those who are worrying could relax.  want to
> > remind that 2-in-1 sale is coming that could beat peers even after a
> > superb Q4.

> > On Nov 30, 11:30 am, JimA <jame...@yahoo.com> wrote:

> > > Anyone looking at the history chart of SVA can easily get an
> > > impression that SVA stock is of one time hit.  It jumped high and then
> > > cooled for a long time.  That is one reason people tend to be scared
> > > and impatient.

> > > Over time, SVA has been changing to a long term deal.  In the coming
> > > months and years, you can expect a constant up trend and more frequent
> > > jumps.  As a result, short traders and busy trading will not win as
> > > much as long term holders.

> > > I do believe there are MMs playing SVA.  One friend said he has to do
> > > fishing to impress his boss with the assigned share building.

> > > I think MMs can only shake off short term traders.

> > > On Nov 30, 11:11 am, JimA <jame...@yahoo.com> wrote:

> > > > Here is the old news.  In one month, SVA is expected to sell 2-in-1
> > > > vaccine.

> > > > One thing that prevents China from vaccinating quickly is that vaccine
> > > > receivers have to wait 2 to 4 weeks between seasonal flu and H1N1.
> > > > There are also conflicts in production.

> > > > One stone is to kill two birds.  With 2-in-1, SVA again will leave
> > > > peers in dust.

> > > > From next year, China will mandate the use of some vaccines to all.
> > > > SVA as the leading vaccine provider in China can never get breaks.- Hide quoted text -

> > > - Show quoted text -- Hide quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> jd, the 2-in-1 is a reminder.

> Half year ago, I got a chance to feel the CEO's ambition, so decided
> to buy SVA with no sale for at least one year.  SVA is pursuing its
> intentions one by one.

> Since I have no intention to play others fear, so want to share my
> positive and do hope those who are worrying could relax.  want to
> remind that 2-in-1 sale is coming that could beat peers even after a
> superb Q4.

> On Nov 30, 11:30 am, JimA <jame...@yahoo.com> wrote:

> > Anyone looking at the history chart of SVA can easily get an
> > impression that SVA stock is of one time hit.  It jumped high and then
> > cooled for a long time.  That is one reason people tend to be scared
> > and impatient.

> > Over time, SVA has been changing to a long term deal.  In the coming
> > months and years, you can expect a constant up trend and more frequent
> > jumps.  As a result, short traders and busy trading will not win as
> > much as long term holders.

> > I do believe there are MMs playing SVA.  One friend said he has to do
> > fishing to impress his boss with the assigned share building.

> > I think MMs can only shake off short term traders.

> > On Nov 30, 11:11 am, JimA <jame...@yahoo.com> wrote:

> > > Here is the old news.  In one month, SVA is expected to sell 2-in-1
> > > vaccine.

> > > One thing that prevents China from vaccinating quickly is that vaccine
> > > receivers have to wait 2 to 4 weeks between seasonal flu and H1N1.
> > > There are also conflicts in production.

> > > One stone is to kill two birds.  With 2-in-1, SVA again will leave
> > > peers in dust.

> > > From next year, China will mandate the use of some vaccines to all.
> > > SVA as the leading vaccine provider in China can never get breaks.- Hide quoted text -

> > - Show quoted text -- Hide quoted text -

> - Show quoted text -

> Anyone looking at the history chart of SVA can easily get an
> impression that SVA stock is of one time hit.  It jumped high and then
> cooled for a long time.  That is one reason people tend to be scared
> and impatient.

> Over time, SVA has been changing to a long term deal.  In the coming
> months and years, you can expect a constant up trend and more frequent
> jumps.  As a result, short traders and busy trading will not win as
> much as long term holders.

> I do believe there are MMs playing SVA.  One friend said he has to do
> fishing to impress his boss with the assigned share building.

> I think MMs can only shake off short term traders.

> On Nov 30, 11:11 am, JimA <jame...@yahoo.com> wrote:

> > Here is the old news.  In one month, SVA is expected to sell 2-in-1
> > vaccine.

> > One thing that prevents China from vaccinating quickly is that vaccine
> > receivers have to wait 2 to 4 weeks between seasonal flu and H1N1.
> > There are also conflicts in production.

> > One stone is to kill two birds.  With 2-in-1, SVA again will leave
> > peers in dust.

> > From next year, China will mandate the use of some vaccines to all.
> > SVA as the leading vaccine provider in China can never get breaks.- Hide quoted text -

> - Show quoted text -

> Here is the old news.  In one month, SVA is expected to sell 2-in-1
> vaccine.

> One thing that prevents China from vaccinating quickly is that vaccine
> receivers have to wait 2 to 4 weeks between seasonal flu and H1N1.
> There are also conflicts in production.

> One stone is to kill two birds.  With 2-in-1, SVA again will leave
> peers in dust.

> From next year, China will mandate the use of some vaccines to all.
> SVA as the leading vaccine provider in China can never get breaks.

> Here is the old news.  In one month, SVA is expected to sell 2-in-1
> vaccine.

> One thing that prevents China from vaccinating quickly is that vaccine
> receivers have to wait 2 to 4 weeks between seasonal flu and H1N1.
> There are also conflicts in production.

> One stone is to kill two birds.  With 2-in-1, SVA again will leave
> peers in dust.

> From next year, China will mandate the use of some vaccines to all.
> SVA as the leading vaccine provider in China can never get breaks.

> When is the presentation??

> On Nov 30, 9:18 am, "M.H." <mnshers...@gmail.com> wrote:

> > good news at the conference..also rumors persist that SVA is testing a
> > 3 in 1 flu vaccine...seasonal, H1N1 and H5N1.

> > On Nov 30, 9:05 am, jd <john.p...@googlemail.com> wrote:

> > > ............and with an $11 target at Piper Jaffray

> > > On Nov 30, 2:02 pm, jd <john.p...@googlemail.com> wrote:

> > > > Sinovac Biotech Ltd. (SVA) Reiterated Overweight at Piper Jaffray

> > > > Might help a bit.
> > > > More favourable broker ratings after presentation?- Hide quoted text -

> - Show quoted text -

> good news at the conference..also rumors persist that SVA is testing a
> 3 in 1 flu vaccine...seasonal, H1N1 and H5N1.

> On Nov 30, 9:05 am, jd <john.p...@googlemail.com> wrote:

> > ............and with an $11 target at Piper Jaffray

> > On Nov 30, 2:02 pm, jd <john.p...@googlemail.com> wrote:

> > > Sinovac Biotech Ltd. (SVA) Reiterated Overweight at Piper Jaffray

> > > Might help a bit.
> > > More favourable broker ratings after presentation?

> ............and with an $11 target at Piper Jaffray

> On Nov 30, 2:02 pm, jd <john.p...@googlemail.com> wrote:

> > Sinovac Biotech Ltd. (SVA) Reiterated Overweight at Piper Jaffray

> > Might help a bit.
> > More favourable broker ratings after presentation?

> Sinovac Biotech Ltd. (SVA) Reiterated Overweight at Piper Jaffray

> Might help a bit.
> More favourable broker ratings after presentation?

> At this point, I think that you may be right on target, but we will
> have a better idea when we watch how trading goes before premarket.

> There may be a wild card in the works.  There's always a chance that
> positive news could break either overnight or when the market opens.
> It has happened before.  We will see.

> On Nov 29, 8:51 pm, Terry <tgres...@gmail.com> wrote:

> > Where are we opening and predictions about where we'll go
> > I say we open near 8 or just above,...and drop all day back to where
> > we are now because MM will do the shorting thing where they buy a
> > bunch, it goes way up and then starts dropping right away so lots of
> > people sell to try and make a few bucks and get rid of their low 7
> > shares. That's my prediction...What's yours??
> > T

> > Oh ...- Hide quoted text -

> - Show quoted text -

> Where are we opening and predictions about where we'll go
> I say we open near 8 or just above,...and drop all day back to where
> we are now because MM will do the shorting thing where they buy a
> bunch, it goes way up and then starts dropping right away so lots of
> people sell to try and make a few bucks and get rid of their low 7
> shares. That's my prediction...What's yours??
> T

> Oh ...

> I am also thinking for short term players although I have no plan to
> sell SVA in the near future (because SVA has a few intentions
> mentioned during its interview with Chinese reporters last month).

> Within next one month, there could be a price spiking if some media
> use the word "order" to report SVA's latest big assignment or another
> coming move.

> Q3 of 600% net income increase was combined with less transparency,
> leaking and fear.  During Piper Jaffray Health Care Conference on
> coming 12-2, SVA CEO will be interviewed.  Such direct talk will
> increase transparency.

> My guess is, SVA could get substantial momentum starting from later
> next month to early next year.  People would sell other winners to buy
> SVA, likely to see its price jumping.

> If you do not believe, then sell it today.  Big number dumping at dips
> can result in higher price in next spike, benefiting longer holders.

> On Nov 27, 10:20 am, JimA <jame...@yahoo.com> wrote:

> > For Your Info -

> > In the past two months, China has reached 1.5% population.  In the
> > next few months, China planned to triple the pace to reach 7.5%
> > population.  It just made new orders to the 7 companies that could
> > produce H1N1.

> > The latest new orders are in the form of production task, not in the
> > word "order", so I guess it might not get reported by media outside of
> > China.

> > The task assigned to SVA is a big number to be set, because Hualan is
> > encountering energy problem.

> > Hualan uses natural gas as the energy of everything.  Hualan with the
> > largest capacity is in Henan Province.  The whole province is now very
> > hard to get enough natural gas.  China is working on that energy
> > problem to help Hualan, hence could add more task to SVA.

> > For SVA, it looks like Q4 earnings should be much better than Q3.

> > Ten companies were working on H1N1 vaccine.  Of the ten, three
> > government owned companies were not successful to provide H1N1
> > vaccine.  SVA vaccine is the first being approved.